Soleno Therapeutics (SLNO) Short term Debt (2013 - 2015)

Soleno Therapeutics (SLNO) has 3 years of Short term Debt data on file, last reported at $865000.0 in Q4 2015.

• Quarterly Short term Debt rose 751.97% year-over-year to $865000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $865000.0 (up 751.97% YoY) and the FY2015 annual result came in at $865000.0, up 751.97% from the prior year.
• Short term Debt declined to $865000.0 in Q4 2015 per SLNO's latest filing, from $3.9 million in the prior quarter.
• Across five years, Short term Debt topped out at $14.0 million in Q4 2013 and bottomed at $101529.0 in Q4 2014.
• The 3-year median for Short term Debt is $3.9 million (2015), against an average of $6.0 million.
• The widest annual swing landed in 2014, when Short term Debt slumped 99.27%; it then jumped 751.97% in 2015.
• Tracing SLNO's Short term Debt over 3 years: stood at $14.0 million in 2013, then tumbled by 99.27% to $101529.0 in 2014, then jumped by 751.97% to $865000.0 in 2015.
• Per Business Quant, the three latest SLNO Short term Debt figures stand at $865000.0 (Q4 2015), $3.9 million (Q3 2015), and $11.0 million (Q2 2015).

Peer Comparison